RNU7-10P

Across TCGA pan-cancer cohorts, RNU7-10P RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated RNU7-10P data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher RNU7-10P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU7-10P expression acts as an unfavorable survival marker.

KIRC, ESCA, and ACC are the cancer types where RNU7-10P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Tertile	All	0.426	0.665	<.001	102	view →
ESCA	OS	Tertile	All	0.470	1.000	<.001	36	view →
ACC	OS	Tertile	III,IV	0.322	0.767	.004	36	view →
PCPG	OS	Tertile	All	0.775	0.980	<.001	36	view →
THCA	OS	Tertile	III,IV	0.321	0.908	.004	33	view →
SKCM	OS	Tertile	IV	0.179	0.755	<.001	18	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

RNU7-10P–KIRC (OS)

Open the KIRC breakdown →